Diabetes Discourse

For clinicians managing patients with T2DM, the clinical landscape for standards of care, diagnostic methods and techniques, and treatment options has become increasingly complex. Yet despite this challenge in keeping up to date with the latest recommendations, updated practice guidelines have also made it a point to emphasize "big picture" elements in diabetes care, reinforcing mainstays of treatment that can potentially get overlooked.

On this episode, Dr. John Russell welcomes diabetes expert Dr Neil Skolnik, Associate Director of Family Medicine at Abington Jefferson Health, to explore the "Back to Basics" model in diabetes management, with emphasis on individualized therapeutic approaches and lifestyle modification strategies for improving long-term patient outcomes.

Diabetes Discourse, a non-certified educational series, is brought to you by AstraZeneca, pushing the boundaries of science to create life-changing medicines for people with diabetes. Content of this diabetes education is produced and solely controlled by ReachMD. This series is intended for healthcare professionals only.

Brought to you by

Host Dr. Farhad Zangeneh welcomes Paresh Dandona MD, PhD, Professor and Chief of Endocrinology in the Department of Medicine at the University of Buffalo. His Specialty and Research Focus are in Endocrinology, Diabetes and Metabolism. He is also the Founder & Medical Director of the Diabetes-Endocrinology Center of Western New York. In this program, Dr. Dandona will be discussing insulin induced cardioprotection, inflammatory and oxidative stress in acute myocardial infarction. He will also review hyperglycemia and cardiotoxicity in acute myocardial infarction. Please take a listen!

What are the sources of glucose in the body? Is diabetes a pancreatic disease or a hepatic disease? What is the importance of glucose toxicity in Type 1 or Type 2 diabetes patients? To answer these questions and many more, join our host Dr. Farhad Zangenh in a discussion with Dr. Robert Rizza, an authority in the regulation of carbohydrate metabolism in humans, and the Executive Dean for Research at Mayo Clinic. Download the podcast and listen in!

What are the sources of glucose in the body? Is diabetes a pancreatic disease or a hepatic disease? What is the importance of glucose toxicity in Type 1 or Type 2 diabetes patients? To answer these questions and many more, join our host Dr. Farhad Zangenh in a discussion with Dr. Robert Rizza, an authority in the regulation of carbohydrate metabolism in humans, and the Executive Dean for Research at Mayo Clinic. Download the podcast and listen in!

In diabetes management, clinicians typically measure glycemic control with fasting plasma glucose (FPG) and premeal glucose measurements, and HbA1c. And, the goals for each of these measurements have been established based on the results of many clinical trials. However, the majority of patients with diabetes fail to achieve these glycemic goals. Elevated postprandial glucose (PPG) concentrations may contribute to suboptimal glycemic control. Host Dr Farhad Zangeneh is joined by Dr. Paul Jellinger who will address the issue of postprandial glucose and its complications.

Paul S. Jellinger, MD and Master of the American College of Endocrinology (MACE) serves as Professor of Medicine on the voluntary faculty at the University of Miami and served as Chief of the Section of Endocrinology at Memorial Regional Hospital in Hollywood, Florida. Dr. Jellinger served as president of the AACE, the ACE and the Florida Endocrine Society. Dr. Jellinger has been active on the AACE Board of Directors.

Dr Farhad Zangeneh is joined by Dr. Yehuda Handelsman, Medical Director at the Metabolic Institute of America; President of the American Association of Clinical Endocrinologists; and, Chair & Program Director, "Annual World Congress on Insulin Resistance, Diabetes & CVD". Dr. Handelsman will discuss the recent growing concerns between diabetes, anti-diabetes agents, and the increased prevalence of various cancers. Currently available data are limited, controversial, and confusing. The AACE and health care providers believe that this is a critically important area that needs further clarification.

Host Dr Farhad Zangeneh welcomes James R. Gavin III, MD, PhD, clinical professor of medicine at Emory University School of Medicine and at the Indiana University School of Medicine. Together they will explore the trends in the growth of diabetes in African Americans, the policies needed to address these problems, and some of the barriers that prevent better outcomes in diabetes care for African Americans and other high-risk minorities.

James R. Gavin III, MD AND PHD, clinical professor of medicine at Emory University School of Medicine and at the Indiana University School of Medicine. Dr. Gavin serves as CEO and Chief Medical Officer of Healing Our Village, Inc. He also belongs to a number of organizations, including the Institute of Medicine, the American Diabetes Association (ADA), the American Society of Clinical Investigation, the American Association of Physicians, and the Atlanta Rotary Club.

Host Dr. Farhad Zangeneh welcomes Dr. Kathleen "Kittie" Wyne from the The Methodist Hospital Research Institute (TMHRI) in Houston where she also coordinates their clinical research program in The Diabetes Research Center. Dr. Wyne discusses the changing classification of diabetes and pre-diabetes and how and when we should make the diagnosis. She also discusses the criteria for both diabetes and pre-diabetes and the tools available for clinicians.

Host Dr. Farhad Zangeneh welcomes Dr. George Grunberger on a discussion on how to attain the best glucose control for our patients and how to do it safely. The discussion stems from altering lifestyle changes for our patients, addressing how to set individualized targets for our patients and identifying whats the best course of action.

Dr. George Grunberger, founder and chairman of the Grunberger Diabetes Institute in Bloomfield Hills, Michigan. He is Clinical Professor of Internal Medicine and Molecular Medicine & Genetics at Wayne State University School of Medicine in Detroit. Dr. Grunberger has published well over 100 original peer-reviewed manuscripts in addition to reviews and book chapters. His research spans subjects from molecular underpinning of insulin resistance to clinical studies on diabetes and its complications.

Host Dr. Farhad Zangeneh welcomes Dr. George Grunberger on a discussion on how to attain the best glucose control for our patients and how to do it safely. The discussion stems from altering lifestyle changes for our patients, addressing how to set individualized targets for our patients and identifying whats the best course of action.

Dr. George Grunberger, founder and chairman of the Grunberger Diabetes Institute in Bloomfield Hills, Michigan. He is Clinical Professor of Internal Medicine and Molecular Medicine & Genetics at Wayne State University School of Medicine in Detroit. Dr. Grunberger has published well over 100 original peer-reviewed manuscripts in addition to reviews and book chapters. His research spans subjects from molecular underpinning of insulin resistance to clinical studies on diabetes and its complications.